Journal of Lipid Research, Vol 38, 2455-2464, Copyright © 1997 by Lipid Research, Inc.

ARTICLES

Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants

J Fruebis, DA Bird, J Pattison and W Palinski
Department of Medicine, University of California, San Diego, La Jolla 92093-0682, USA.

Oxidation of LDL plays all important role in atherogenesis. The lag- time in the formation of conjugated dienes provides a sensitive measure of the resistance of plasma LDL to oxidation and is widely assumed to be an indicator of atherogenic risk. To test this assumption, we investigated whether different antioxidants yielding similar lag-times result in similar reduction of atherosclerosis. A 6-months intervention study was carried out in three groups of 10 LDL receptor-deficient rabbits each. Because previous studies indicated that antioxidants that reduce atherosclerosis resulted in very long lag-times, the first group was treated with an antioxidant combination containing 1,000 IU vitamin E, 0.05% probucol analogue (BM15.0639), and 0.025% probucol. The lag- times achieved throughout the intervention period by this combination (952 +/- 39 min) were matched in a second group (829 +/- 46 min) treated with a variable dose of probucol (0.0575-0.11%, average 0.091%). A third, untreated group served as a control. Plasma cholesterol levels of all groups were matched. Even though both treatments yielded similar antioxidant protection of plasma LDL, 0.091% probucol reduced aortic atherosclerosis by 51.7% compared to the untreated group (P < 0.005), whereas the antioxidant combination failed to reduce lesion formation. Thus, the lag-time is clearly not correlated with the antiatherogenic efficacy of different antioxidants. However, a weak correlation was found within the group treated with probucol only. Our results suggest that the degree of antioxidant protection of plasma LDL may not be a good indicator of the atherogenic risk, in general, and that probucol reduces atherogenesis by mechanisms not shared by all antioxidants.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. A. Atkin, A. Gasper, R. Ullegaddi, and H. J. Powers Oxidative Susceptibility of Unfractionated Serum or Plasma: Response to Antioxidants in Vitro and to Antioxidant Supplementation Clin. Chem., November 1, 2005; 51(11): 2138 - 2144. [Abstract] [Full Text] [PDF]

				R. Stocker and R. A O'Halloran Dealcoholized red wine decreases atherosclerosis in apolipoprotein E gene-deficient mice independently of inhibition of lipid peroxidation in the artery wall Am. J. Clinical Nutrition, January 1, 2004; 79(1): 123 - 130. [Abstract] [Full Text] [PDF]

				M. ZEMAN, A. ZAK, M. VECKA, E. TVRZICKA, S. ROMANIV, and M. KONARKOVA Treatment of Hypertriglyceridemia with Fenofibrate, Fatty Acid Composition of Plasma and LDL, and Their Relations to Parameters of Lipoperoxidation of LDL Ann. N.Y. Acad. Sci., June 1, 2002; 967(1): 336 - 341. [Abstract] [Full Text] [PDF]

				D. Steinberg and J. L. Witztum Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?: Do the Antioxidant Trials Conducted to Date Refute the Hypothesis? Circulation, April 30, 2002; 105(17): 2107 - 2111. [Full Text] [PDF]

				M. Wagberg, A.-H. Jansson, C. Westerlund, A.-M. Ostlund-Lindqvist, B. Sarnstrand, H. Bergstrand, and K. Pettersson N,N'-Diacetyl-L-cystine (DiNAC), the Disulphide Dimer of N-Acetylcysteine, Inhibits Atherosclerosis in WHHL Rabbits: Evidence for Immunomodulatory Agents as a New Approach to Prevent Atherosclerosis J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 76 - 82. [Abstract] [Full Text] [PDF]

				B. Poirier, O. Michel, R. Bazin, J. Bariety, J. Chevalier, I. Myara, and A.-T. Gaston Conjugated dienes: a critical trait of lipoprotein oxidizability in renal fibrosis Nephrol. Dial. Transplant., August 1, 2001; 16(8): 1598 - 1606. [Abstract] [Full Text] [PDF]

				M. A. Ostos, M. Conconi, L. Vergnes, N. Baroukh, J. Ribalta, J. Girona, J.-M. Caillaud, A. Ochoa, and M. M. Zakin Antioxidative and Antiatherosclerotic Effects of Human Apolipoprotein A-IV in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 1023 - 1028. [Abstract] [Full Text] [PDF]

				S. Yu-Poth, T. D. Etherton, C. C. Reddy, T. A. Pearson, R. Reed, G. Zhao, S. Jonnalagadda, Y. Wan, and P. M. Kris-Etherton Lowering Dietary Saturated Fat and Total Fat Reduces the Oxidative Susceptibility of LDL in Healthy Men and Women J. Nutr., September 1, 2000; 130(9): 2228 - 2237. [Abstract] [Full Text]

				H. Wiseman, J. D O'Reilly, H. Adlercreutz, A. I Mallet, E. A Bowey, I. R Rowland, and T. A. Sanders Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans Am. J. Clinical Nutrition, August 1, 2000; 72(2): 395 - 400. [Abstract] [Full Text] [PDF]

				P. V. Subbaiah, V. S. Subramanian, and K. Wang Novel Physiological Function of Sphingomyelin in Plasma. INHIBITION OF LIPID PEROXIDATION IN LOW DENSITY LIPOPROTEINS J. Biol. Chem., December 17, 1999; 274(51): 36409 - 36414. [Abstract] [Full Text] [PDF]

				S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac Oxidants and antioxidants in atherogenesis: an appraisal J. Lipid Res., December 1, 1999; 40(12): 2143 - 2157. [Abstract] [Full Text] [PDF]

				J. Fruebis, M. Silvestre, D. Shelton, C. Napoli, and W. Palinski Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits J. Lipid Res., November 1, 1999; 40(11): 1958 - 1966. [Abstract] [Full Text]

				P. K. WITTING, K. PETTERSSON, A.-M. ÖSTLUND-LINDQVIST, C. WESTERLUND, A. W. ERIKSSON, and R. STOCKER Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice FASEB J, April 1, 1999; 13(6): 667 - 675. [Abstract] [Full Text]

				D. A. Bird, R. K. Tangirala, J. Fruebis, D. Steinberg, J. L. Witztum, and W. Palinski Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice J. Lipid Res., May 1, 1998; 39(5): 1079 - 1090. [Abstract] [Full Text] [PDF]